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Myocardial contractile power diminishes rapidly when minute quantities  of 
streptolysin O  are perfnsed through  the vigorously beating isolated hearts  of 
guinea pigs, rabbits, and rats, as recent investigations have shown (1).  From 
experiments undertaken  to disclose more about this phenomenon it  has now 
been  learned  that  partially  purified  preparations  of  streptococcal  filtrates 
containing  streptolysin  O  will  regularly inhibit  the  oxidative metabolism  of 
mitochondria procured from the myocardium of rabbits when certain constit- 
uents of the citric acid cycle are employed as substrate,  the finding suggesting 
that  the activity of the coenzyme diphosphopyridine nucleotide  (DPN)  is in 
some manner altered. Also, the agent in the solutions which is responsible for 
this effect has been found to differ from streptolysin O in a number of important 
respects. 
Materials and Methods 
Preparations of streptococcal filtrates containing streptolysin 0  were added 
to suspensions of mitochondria obtained from the myocardlum of rabbits, and 
the  effect on oxygen consumption  by the mitochondria was observed in  the 
Warburg apparatus in the presence of a  number of different substrates. 
Streptococcal Filtratea.--Preparations of streptococcal filtrates containing streptolysin O 
were made from cultures of the  C203S strain  of group A streptococcus according to the 
method previously described (1). The solutions were dialyzed overnight prior  to use, and 
were activated with equal parts of 1 per cent cysteine in all instances unless otherwise indi- 
cated. Four different batches, ranging in streptolysin O activity from 10,000 to 53,000 hemo- 
lytic units per ml., were employed in these studies, and the same results were obtained with 
each. 
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Animcds.--Normal, adult, market-bought rabbits of both sexes and mixed breeds, weighing 
between 2,500 and 4,000 gin., were used. They were maintained on a diet of Rockland rabbit 
pellets supplemented with greens. 
Mitochondria.--Suspensions of  mitochondria were  prepared  from  the hearts  of  rabbits 
using the  procedure  described  in  detail  by  Harman  and  Osborne  for mitochondria from 
the pectoralis muscle of wild captive pigeons (2). No attempt was made, however, to separate 
the mitochondtia from the "sarcosomes," because these investigators have shown that the 
latter particles  contribute chiefly an accelerating effect  to  the  metabolic processes  of  the 
mitochondria and have only minor oxidative capacity themselves. In one experiment, the 
mitochondrial suspension employed  was  prepared  from  the  hearts  of  two  normal guinea 
pigs. The mitochondria were suspended in 0.25 ~  sucrose solution and stored at 0°C. until 
used. They were always used within 5 hours from the time of homogen/zatiom The oxygen 
consumption of  such suspensions in the absence of  substrate was  found repeatedly  to be 
negligible. 
Meazurem~t of Oxygen Consuraption.--The oxygen  consumption of  mitochondria was 
measured at 37°C.  in Warburg flasks fitted with sidearms. Air was used as the gas phase, 
and strips of filter paper wetted with 0.2 ml. of  I0 per cent potassium hydroxide solution 
were placed in the center well to absorb carbon dioxide. In the main chamber of the flasks 
was placed 1.4 ml. of 0.25 M sucrose solution containing the following substances: potassium 
phosphate buffer at pH 7.2---60/z~; magnesium chloride--16/z~; adenosine monophosphate 
(AMP) 1 of  muscle  origin--2.4  mg.;  diphosphopyridine nucleotide  (DPN)L-2.0  rag.;  and 
40/z~ of the substrate to be used brought to pit 7.2 with I0 per cent potassium hydroxide. 
In addition, there was added 0.5  ml. of the suspension of mitochondria in 0.25 ~  sucrose 
solution. The sidearms contained the streptolysin O solution or other test materials dissolved 
in 0.1 ml. of 0.25 ~  sucrose solution. The stopcocks were closed after a  15 minute preliminary 
equilibration period,  and oxygen consumption was measured at  intervals of  5  minutes by 
the constant volume manometric techniques described by Umbreit, Burris, and Stauffer (3). 
The contents of  the flasks were permitted to incubate for  10 or  15  minutes following the 
equilibration period. The material in the sidearm was then tipped into the main chamber 
and the sidearm was rinsed three times with the contents of the main chamber to insure 
adequate mixing. Measurements of oxygen consumption were continued at 5 minute inter- 
vals for 45 to 60 minutes. 
EXPERIMENTAL 
The Esffect of Solutions Containing Streptolysin 0  on the Oxidative Metabolism of 
Suspensions of Mitochondria from Rabbit Myocardium 
One  of  the  possible  explanations  for  the  loss  of  contractility  induced  in 
isolated and perfused mammalian  hearts by streptolysin O  is an interference 
with a  metabolic  pathway essential for the production of energy.  Since it is 
known that mitochondria are responsible for most of  the intracellular meta- 
bolic processes involved in the production of energy (2),  a  number of experi- 
ments  were  done  to  learn  whether  the metabolic  activities  of  mitochondria 
from  the  heart  muscle  of  rabbits  were  influenced  by  solutions  containing 
streptolysin O. 
1 AMP  was obtained  from  Nutritional  Biochemicals  Corporation,  Cleveland,  and  DPN 
from Sigma Chemical Co.,  St. Louis. A.  S.  CARLSON,  A.  KELLNER,  A.  W.  BERN/:tEIM~ER  579 
The utilization of oxygen by suspensions of mitochondria was measured in the Warburg 
apparatus  using the  potassium salt  of one of the  following components of the citric acid 
cycle as the  substrate  in  each case: citric acid, succinic acid, aipha-ketoglutaric add, or 
fumaric acid. The streptolysin O solutions were activated  with cysteine and  diluted with 
0.25 ~ sucrose solution to contain 2,000 hemolytic units per ml.; 0.1 ml. of this solution was 
placed in the sidearm, so that the final concentration of streptolysin O in the main chamber 
was 100 hemolytic units per ml. In each experiment there were control flasks the sidearms of 
which contained either cysteine or 0.23 ~  sucrose solution but no  streptolysin O.  The con- 
centration of cysteine in the sidearms of the control flasks was the same as that  present in 
the streptolysin O solutions following activation and dilution to the desired strength. 
It  was  found  repeatedly  that  the  rate  of  utilization  of  oxygen  began  to 
decrease within  10 minutes following the addition  of the streptolysin O solu- 
tions in those flasks containing either citrate, fumarate, or alpha-ketoglutarate. 
Oxygen utilization  ceased  completely in  the  citrate-containing  flasks within 
20  to 40 minutes;  it continued,  though  at a  very much reduced  rate, in  the 
flasks with fumarate and alpha-ketoglutarate. In the flasks in which succinate 
was the substrate, on the other hand, the rate of oxygen uptake was not influ- 
enced by the addition of the streptolysin O solutions. Oxygen consumption by 
the suspensions of mitochondria in the control flasks containing either cysteine 
or sucrose solution in  the sidearms continued  normally for an hour or more. 
The results of a typical experiment are illustrated in Fig. 1. In other experiments 
the  concentration  of streptolysin O  was increased  two-  to fourfold,  and  the 
same effect was obtained; when the concentration of streptolysin O was reduced 
to 25 units per ml., the results were similar, though less striking. 
To  learn  whether  mitochondria  from  the  myocardium  of, other  animal 
species would  be affected in a  similar fashion,  an experiment was done with 
mitochondria obtained from the hearts of two normal guinea pigs. The solution 
of streptolysin O  inhibited  completely the oxidation  of citrate  by this mito- 
chondrial suspension while that of succinate was not affected, the findings being 
precisely the same as those with mitochondria from rabbit myocardium. 
It  was  clear  from  these  experiments  that  preparations  of  streptococcal 
filtrates containing streptolysin O  interfered with  the ability of mitochondria 
procured from the myocardium of rabbits and guinea  pigs  to utilize  citrate, 
fumarate,  and  alpha-ketoglutarate,  but  not  with  their ability to utilize  suc- 
cinate.  Since it is known that oxidation of the former substrates requires the 
coenzyme DPN as an essential constituent of the system whereas oxidation of 
succinate  does  not  (4-7),  the  findings  pointed  to  a  selective destruction  or 
inhibition of DPN by streptolysin O or by some other agent or agents present in 
the solutions. To shed further light on this point, an experiment was done in 
which the DPN was omitted from the main chamber but was incubated in the 
sidearm together with the solutions of streptolysin O. 
Effect on Oxygen Uptake of Prior Incubation of DPN with Solutions of Strepto- 
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Fro.  1.  Oxygen consumption by suspensions of mitochondria from the  myocardium  of 
rabbits in the presence of 40/tx{ of the following substrates: A-citrate;  B--fumarate; C-- 
alpha-ketoglutarate; D---succinate. The sidearms contained either 0.1 ml. of  a  solution of 
cysteine-activated streptolysin O having 2,000 hemolytic units per  ml.  (SO), or 0.1 ml. of a 
control solution containing cysteine in the same concentration as that present in the strepto- 
lysin O solution (Control). 
The arrows in this and in succeeding figures indicate the point at  which the contents of 
the sidearm were added to the main chamber. 
Four  Warburg flasks were  set up,  the main chamber in each case containing the  con- 
stituents previously  described with the exception of  DPN;  the substrate employed  in all 
cases was citrate. The materials placed in the sidearms were as follows: flask  1--2 mg. DPN 
plus the streptococcal solution containing 200 hemolytic units of streptolysin O  in 0.2 ml. A.  S.  CARLSON~  A.  KELLNER~  A.  W.  BERN1TEIMER  581 
phosphate  buffer;  flask  2--2  rag.  DPN  in  0.2  ml.  phosphate  buffer  containing  cysteine; 
flask  3--0.2  ml.  streptolysin O  solution containing  200  hemolytic units;  flask  4--0.2  ml. 
phosphate buffer.  Two additional flasks  (Nos. 5 and 6) were set up with citrate as the sub- 
strate and 2 nag. DPN in the main chamber in each case; the sidearm of flask  5 contained 
200 hemolytic units of the streptolysin O solution in 0.1  ml. phosphate buffer,  and  that  of 
flask 6, 0.1  ml. phosphate buffer with cysteine. 0.15 a  phosphate  buffer at pH 7.2 and con- 
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FIG,  2.  Effect on oxygen uptake  of incubating DPN in the sidearm  with a  solution of 
streptolysin O. 40 #at citrate was the substrate in all flasks. 
Flasks  1 to 4. No DPN in main chamber.  Sidearms:  1.  2 nag. DPN; cystelne-activated 
solution of streptolysin O, 200 hemolytic units. 2. 2 rag. DPN; cysteine. 3. No DPN; cysteine- 
activated solution of streptolysin O, 200 hemolytic units. 4. No DPN; phosphate buffer. 
Flasks 5 and 6, 2 rag.  DPN in main chamber. Sidearms: 5. Cysteine-activated solution of 
streptolysin O, 200 hemolytic units. 6. Cysteine. No streptolysin O solution. 
taining 0.25  ~  sucrose was used  throughout.  The concentration  of cysteine employed was 
the same as  that present in the streptolysin  O  solutions following activation and  dilution 
to the desired strength.  The rate of oxygen consumption was measured  for a  period of 10 
minutes following equilibration; the contents of the sidearms were then tipped in and oxygen 
consumption was recorded at 5 minute intervMs for 1 hour. 
The results of this experiment are illustrated in Fig. 2. In flask 1, the sidearm 
of which contained DPN  plus the solution of streptolysin O, oxygen utilization 582  INHIBITION OF  OXIDATIVE METABOLISM 
was zero both before and after the addition of the contents of the sidearm. In 
flask 2, by contrast, where the DPN in the sidearm had not been incubated 
in the presence of the streptolysin O solution, oxygen consumption, which had 
previously been zero, increased sharply following addition of the contents of 
the sidearm and continued at a  high rate for the duration of the experiment. 
There was no measurable oxygen uptake in flasks 3 and 4, which did not contain 
DPN in either the sidearms or the main chambers. In flask 6, which contained 
DPN in  the  main  chamber  and  no  streptolysin O  solution  in  the  sidearm, 
oxygen uptake continued at a rapid rate throughout the period of observation, 
whereas in flask 5, there was inhibition of oxidative metabolism following the 
addition of the streptolysin O solution from the sidearm.  In a  similar experi- 
ment, but with succinate as the substrate,  oxygen consumption was found to 
continue unabated in all flasks whether or not DPN was present. The findings 
of these experiments made it plain that incubation of DPN with the solution 
of streptolysin O in some manner altered the DPN so that it was not available 
for the oxidation of citrate. 
Nature of the Active Material 
Solutions of streptolysin 0  such as were employed in these experiments are 
known to contain, in addition to streptolysin O, a number of other substances 
which have not as yet been isolated or identified. Hence it became essential to 
learn  whether  the  selective  inhibition  of the  oxidative  metabolism  of mito- 
chondria is brought about by the streptolysin 0  itself or by some other agent 
or agents contained in the solutions. An experiment was first done to determine 
whether the active substance was of streptococcal origin or a constituent of the 
medium in which the streptococci were grown. 
A sample of the sterile culture medium used for the growth of the streptococci in the 
preparation of streptolysin 0  was concentrated to ~'~00 of its  volume by pervaporation 
from a cellophane sac. Thi  s solution was then dialyzed overnight against running tap water, 
following which it was again concentrated to ~'~0o of the original volume by pervaporation. 
This concentrate  of the non-dialyzable  constituents of the culture medium, in 0.1 ml. amounts, 
was tested in the Warburg apparatus for its effect on the oxidation of citrate by suspensions 
of mitochondria. It was found that oxygen consumption in the presence of this concentrate 
of the culture medium continued uninterrupted for more than 1 hour and at the same rate 
as that in control flasks not containing the concentrate. 
It was apparent from this experiment that the factor responsible for inhibit- 
ing  the  metabolism  of  mitochondria  was  not  a  constituent  of  the  culture 
medium carried  along fortuitously through the fractionation procedure used 
to prepare streptolysin O, but rather, that it was a product of the streptococcus. 
A  number of studies  were  then done to determine,  ff possible,  whether  this 
factor was identical with streptolysin 0  or distinct from it. A.  S. CARLSON~  A. KELLNER~  A. W. BERNH~IMER  583 
Effect of Heat on Capacity to Inhibit Oxygen Uptake.--Streptolysin 0 is known 
to be quite heat-labile, its hemolytic activity being destroyed by brief exposure 
to a  temperature of 55°C.  (8). 
Solutions of streptolysin 0  were heated at 55°C.  for 10 minutes, activated with cysteine, 
and  their effect  on  the oxygen consumption of mitochondria was  then tested in Warburg 
flasks with dtrate as the substrate. 
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FIG. 3. The effect of heat on the ability of solutions containing streptolysin O to inhibit 
the oxidative metabolism of mitochondria. 40 p~ citrate was the substrate in each case. The 
sidearms contained either 0.i mi. of streptolysin O solution, 2,000 hemolytic units per ml., 
heated at 55°C. for 10 minutes (SO heated), or the same amount of streptolysin O solution 
not subjected to heating (SO unheated). 
The heat-treated solutions of streptolysin O  failed to retard the utilization 
of  oxygen by the  mitochondria,  whereas  the  solutions  containing  the  same 
amount of streptolysin O but not subjected to heat inhibited oxygen utilization 
completely (see Fig. 3). 
Activation  witk Cysteine.--The hemolytic activity of streptolysin O requires 
prior activation with cysteine or other sulfhydryl compounds, as is well known. 
To learn  whether  the  inhibitory  effect on  oxidative metabolism exerted  by 
solutions  containing  streptolysin O  also  required  activation  by cysteine,  an 
experiment was done in which  the rate of oxygen utilization by mitochondria 
was determined following the addition to Warburg flasks of solutions of strepto- 584  INHIBITION  OF  OXIDATIVE  METABOLISM 
lysin 0  with and without prior activation by cysteine. The substrate used in 
each case was citrate. Oxygen uptake was inhibited completely in the flasks 
in which the streptolysin 0  had not been activated with cysteine as well as 
those in which it had. It should be pointed out, however, that the suspensions 
of mitochondria might have contained small amounts of reducing substances 
capable of activating the streptolysin O, and this possibility was not ruled out 
in these experiments. 
Inhibition of Streptolysin 0  by Cholesterol and by Specific Antibody.-- 
Solutions of streptolysin 0  were treated with cysteine and then incubated either with 
suspensions of cholesterol or with horse antistreptolysin globulins  2 according to procedures 
previously described to inactivate the hemolysin (1). These solutions were then tested for 
hemolytic activity and for their ability to inhibit the oxidation of citrate by suspensions of 
mitochondria. 
The hemolytic activity of the streptolysin O  was  in each case  completely 
neutralized as  could be demonstrated readily by failure of  the  solutions to 
lyse rabbit red blood cells; nevertheless, both the  cholesterol-treated and the 
antibody-treated solutions of streptolysin O inhibited completely the utilization 
of oxygen by the mitochondria. Control solutions, containing either cholesterol 
or antibody in the same concentrations as those present in  the  solutions of 
streptolysin O, had no effect on oxygen uptake. 
Erylhrogenic Toxin.--Halbert,  using  agar  diffusion techniques,  has  found 
evidence for the  presence of erythrogenic toxin  in concentrated solutions of 
streptolysin 0  similar to those employed in these studies (9). Hence, an experi- 
ment was done to learn whether erythrogenic toxin was the factor responsible 
for inhibiting the oxidative metabolism of suspensions of mitochondria. It was 
found that oxygen consumption continued without interruption when erythro- 
genie toxin,* in amounts of 100,000 skin test doses, was added to mitochondrial 
suspensions in Warburg flasks in the presence of 40 g~ of citrate as  the  sub- 
strate. 
These experiments demonstrated that the agent in the  solutions of strepto- 
lysin 0  which  is responsible  for inhibiting  the  oxidative processes of mito- 
chondria was a product of the streptococcus. Furthermore, the agent proved to 
be like streptolysin 0  in  that it was  non-dialyzable  and  heat-labile;  it was 
unlike streptolysin 0  in that it appeared not to require prior  activation with 
cysteine, and its action was  not abolished by treatment with  cholesterol or 
antistreptolysin globulins. 
2  Antistreptolysin globulins, 20,000 units  per  mh  Batch  7,  19-947. Serum Institute, 
Carshalton, England. 
a The erythrogenic toxin was kindly supplied by Dr. A. M. Pappenheimer, Jr.,  of the 
Department of Microbiology,  New York University College of Medicine, and contained one 
million skin test doses per milliliter. A. S. CARLSON, A.  KELLNER,  A.  W.  BERNHEIMER  585 
DISCUSSION 
The findings  herein described  make it plain  that fractionated and highly 
concentrated  preparations  of  streptococcal  filtrates  containing  streptolysin 
0  exert a pronounced inhibitory effect on the ability of mitochondria obtained 
from the cardiac muscle of rabbits to metabolize  citrate, alpha-ketoglutarate, 
and fumarate, but have no effect on the metabolism of succinate. This selective 
inhibition of oxidative metabolism  pointed to an interference  with the action 
of DPN, which is essential for the oxidation of the former but not the latter. 
Further evidence for interference with the action of DPN was provided by the 
observation  that incubation of DPN  together with solutions  of streptolysin 
0  in the sidearm  of the flasks rendered  the DPN unavailable  for metabolic 
activities when it was subsequently added to the main chamber.  The manner 
in which solutions of streptotysin  0  affect DPN, whether by enzymatic degrada- 
tion,  or by combination with it, or  by other means,  was not determined in 
these studies. 
The agent in the solutions  of streptolysin 0  responsible for the inhibitory 
effect on oxidative metabolism was clearly of streptococcal  origin, since con- 
centrates of the non-dialyzable  fraction of the culture medium used  to grow 
the organism in the production of streptolysin 0 had no effect on the metabolism 
of mitochondria. Moreover,  since four lots of streptolysin 0  prepared at dif- 
ferent times had essentially the same inhibitory  effect, it would seem that the fac- 
tor in question is produced regularly  by  the strain of streptococcus, and under the 
conditions of growth, employed for the preparation of streptolysin 0. The agent, 
like streptolysin O, is non-dialyzable  and heat-labile.  It differs notably from 
streptolysin 0, however,  in two respects:  it does not appear to require  prior 
activation with cysteine, as does the hemolytic activity of streptolysin 0; and 
its action is not abolished  by treatment with cholesterol  or antistreptolysin 
globulins,  procedures  which  inhibit  completely  the  hemolytic  activity  of 
streptolysin 0. 
The loss of myocardial contractility that ensues when solutions of strepto- 
lysin 0  are perfused  through the isolated and beating hearts of frogs, rabbits, 
guinea pigs, and rats (10, 1) may perhaps  be related to the marked inhibitory 
effect  such  solutions  have on  the oxidative metabolism  of mitochondria.  It 
should  be pointed out, however,  that the effect on myocardial contractility 
required activation of the solutions with cysteine and was nullified completely 
by the addition to the solutions  of cholesterol  or antistreptolysin globulins, 
procedures which did not influence in any way the ability of the same solutions 
to inhibit the metabolism of mitochondria in vitro.  It is likely that further 
characterization,  and  possibly  isolation,  of  the  agent  affecting  oxidative 
metabolism will be required in order to determine more precisely what relation- 
ship, if any, this substance has to the loss of myocardial contractile power. 586  INHIBITION  OF  OXIDATIVE METABOLISM 
Studies only recently completed have shown that concentrated and partially 
purified preparations of streptolysin O  contain an enzyme, not hitherto de- 
scribed in streptococcal filtrates, which destroys DPN.  Furthermore, it has 
been possible by means of electrochromatographic fractionation to separate 
this  enzyme from streptolysin O.  The  enzyme, streptococcal  DPNase,  was 
found to be heat-labile, to have its optimal effect at pH 7.3, and to act specif- 
icaily upon the oxidized form of DPN and not upon reduced DPN or triphos- 
phopyridine nucleotide (TPN). The characterization of streptococcal DPNase 
and its separation from streptolysin O will be described in detail in a separate 
publication (11). 
SUMMARY 
When solutions of streptolysin O were added to Warburg flasks containing, 
among other constituents, suspensions of mitochondria from the myocardinm 
of rabbits and citrate, fumarate, or alpha-ketoglutarate as the substrate, there 
followed regularly a  sharp reduction,  and  eventually complete cessation,  of 
oxygen consumption. This phenomenon was not observed when succinate was 
the substrate in the flasks, the finding pointing to a selective interference with 
DPN as the underlying change. 
The agent in the solutions of streptolysin O responsible for this effect was 
shown to be a streptococcal product, and to he non-dialyzable and heat-labile. 
It differed from streptolysin O in that it did not appear to require prior activa- 
tion with cysteine, and its effectiveness was not diminished by treatment with 
cholesterol or antistreptolysin globulins. 
The authors wish to express their thanks to Edda M. Schweid and to Rudolf G. Brautigam 
for valuable technical assistance. 
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